Physician profile
Rohit Parihar
NPI 1912134818
$932.26
in general payments reported to CMS, 2019-2025
13 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2021: $180 · 2022: $106 · 2023: $102 · 2024: $152 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456 · Consulting Fee: $37.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.74 |
| Consulting Fee | $37.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.33 | 2023-2025 | |
| Alcon Vision LLC | $190.51 | 2019-2025 | Clareon |
| Eyepoint US, INC. | $105.83 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $79.55 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $67.50 | 2024-2025 | Stellaris, Envista Envy Iol |
| Oyster Point Pharma, INC. | $48.87 | 2025 | Ryzumvi, Tyrvaya |
| Sun Pharmaceutical Industries INC. | $39.86 | 2023 | Cequa |
| Adma Biomanufacturing LLC | $37.98 | 2024 | |
| New World Medical,INC. | $35.53 | 2019 | |
| Allergan, INC. | $18.36 | 2019 | |
| Rxsight INC | $18.31 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Omeros Corporation | $16.45 | 2019 | |
| Shire North American Group INC | $14.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Parihar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.